iifl-logo

Orchid Pharma Ltd Nine Monthly Results

801
(-4.12%)
Apr 30, 2025|03:56:32 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Financials

Particulars (Rupees in Crores.)Dec-2024Dec-2023Dec-2022Dec-2021Dec-2020

Gross Sales

684.45

602.27

456

381.43

330.5

Excise Duty

0

0

0

0

0

Net Sales

684.45

602.27

456

381.43

330.5

Other Operating Income

0

0

0

0

0

Other Income

23.58

17.86

17.7

67.65

3.94

Total Income

708.02

620.12

473.7

449.07

334.44

Total Expenditure

595.25

521.42

412.07

356.48

298.2

PBIDT

112.77

98.7

61.63

92.59

36.24

Interest

10.63

12.89

24.74

27.55

39.45

PBDT

102.14

85.81

36.89

65.04

-3.21

Depreciation

25.67

24.82

47.57

60.4

88.59

Minority Interest Before NP

0

0

0

0

0

Tax

-0.15

0

0

0

0

Deferred Tax

0

0

0

0

0

Reported Profit After Tax

76.62

60.99

-10.68

4.64

-91.8

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

77.36

58.64

-12.82

4.64

-91.8

Extra-ordinary Items

0

0

0

60.39

0

Adjusted Profit After Extra-ordinary item

77.36

58.64

-12.82

-55.75

-91.8

EPS (Unit Curr.)

15.25

12.32

-3.14

1.13

-22.49

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

50.72

50.72

40.82

40.82

40.82

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

16.47

16.38

13.51

24.27

10.96

PBDTM(%)

14.92

14.24

8.08

17.05

-0.97

PATM(%)

11.19

10.12

-2.34

1.21

-27.77

Orchid Pharma: Related NEWS

Orchid Pharma Clears USFDA Inspection, Secures EU GMP Renewal
20 Feb 2025|03:36 PM

The inspection raised, seven minor observations none related to data integrity, and therefore, the facility remains compliant under stringent regulatory standards.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.